PALI-2108 is an investigational, gut-activated, once-daily oral PDE4 inhibitor prodrug designed for sustained exposure and anti-inflammatory activity with the potential to improve tolerability ...
A systematic benchmark of fifteen activation functions across CT, mammography and MRI deblurring finds that the spatially ...
Boost ROI by aligning PIC designs to applications, securing scalable packaging and multi-source supply, and using automation, partnerships and system-level validation.Dublin, Oct. (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results